Cargando…

Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats

BACKGROUND: Alterations of the expression of microRNAs (miRNAs) in chronic pain models seem to play a crucial role in the development of neuropathic pain, with microRNA-1 (miR-1) being of particular interest. Recently, we were able to show that decreased miR-1 levels were associated with increased e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuebart, Anne, Wollborn, Verena, Huhn, Ragnar, Hermanns, Henning, Werdehausen, Robert, Brandenburger, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671483/
https://www.ncbi.nlm.nih.gov/pubmed/33223847
http://dx.doi.org/10.2147/JPR.S266937
_version_ 1783610935464689664
author Kuebart, Anne
Wollborn, Verena
Huhn, Ragnar
Hermanns, Henning
Werdehausen, Robert
Brandenburger, Timo
author_facet Kuebart, Anne
Wollborn, Verena
Huhn, Ragnar
Hermanns, Henning
Werdehausen, Robert
Brandenburger, Timo
author_sort Kuebart, Anne
collection PubMed
description BACKGROUND: Alterations of the expression of microRNAs (miRNAs) in chronic pain models seem to play a crucial role in the development of neuropathic pain, with microRNA-1 (miR-1) being of particular interest. Recently, we were able to show that decreased miR-1 levels were associated with increased expression of brain-derived neurotrophic factor (BDNF) and Connexin 43 (Cx43). We hypothesized that miR-1 mimetic nucleotides could alleviate neuropathic pain caused by chronic constriction injury in rats. METHODS: MiR-1 mimetic nucleotides were evaluated for effectiveness, functionality, and intracellular stability by transfecting human glioblastoma cells (U-87 MG). In vivo transfection with miR-1 mimics and corresponding scrambled miRNAs serving as control was performed by repetitive injection (days 0, 3, and 7) into the sciatic nerve following chronic constriction injury (CCI) in rats. Quantitative PCR was used to measure miR-1 content. Cx43 expression was determined by Western blot analysis. Effects on neuropathic pain were assessed by detecting paw withdrawal thresholds using an automated filament application. RESULTS: Transfection of miR-1 mimics was confirmed in U-87 MG cells, with miR-1 content being increased significantly after 48 h and after 96 h (p<0.05). Effective downregulation of Cx43 expression was observed 48 and 96 h after transfection (−44 ± 0.07% and −40 ± 0.11%; p<0.05). In vivo, repetitive transfection with miR-1 mimetic nucleotides led to a 17.9-fold (± 14.2) increase of miR-1 in the sciatic nerve. However, the protein expression of Cx43 in sciatic nerves as well as paw withdrawal thresholds for mechanical stimulation was not significantly increased 10 days after chronic constriction injury. CONCLUSION: While transfection with miR-1 mimics effective reduces Cx43 expression in vitro and restores miR-1 after CCI, we did neither observe altered levels of Cx43 protein level in nerves nor a beneficial effect on mechanical allodynia in vivo, most likely caused by insufficient Cx43 suppression.
format Online
Article
Text
id pubmed-7671483
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76714832020-11-20 Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats Kuebart, Anne Wollborn, Verena Huhn, Ragnar Hermanns, Henning Werdehausen, Robert Brandenburger, Timo J Pain Res Original Research BACKGROUND: Alterations of the expression of microRNAs (miRNAs) in chronic pain models seem to play a crucial role in the development of neuropathic pain, with microRNA-1 (miR-1) being of particular interest. Recently, we were able to show that decreased miR-1 levels were associated with increased expression of brain-derived neurotrophic factor (BDNF) and Connexin 43 (Cx43). We hypothesized that miR-1 mimetic nucleotides could alleviate neuropathic pain caused by chronic constriction injury in rats. METHODS: MiR-1 mimetic nucleotides were evaluated for effectiveness, functionality, and intracellular stability by transfecting human glioblastoma cells (U-87 MG). In vivo transfection with miR-1 mimics and corresponding scrambled miRNAs serving as control was performed by repetitive injection (days 0, 3, and 7) into the sciatic nerve following chronic constriction injury (CCI) in rats. Quantitative PCR was used to measure miR-1 content. Cx43 expression was determined by Western blot analysis. Effects on neuropathic pain were assessed by detecting paw withdrawal thresholds using an automated filament application. RESULTS: Transfection of miR-1 mimics was confirmed in U-87 MG cells, with miR-1 content being increased significantly after 48 h and after 96 h (p<0.05). Effective downregulation of Cx43 expression was observed 48 and 96 h after transfection (−44 ± 0.07% and −40 ± 0.11%; p<0.05). In vivo, repetitive transfection with miR-1 mimetic nucleotides led to a 17.9-fold (± 14.2) increase of miR-1 in the sciatic nerve. However, the protein expression of Cx43 in sciatic nerves as well as paw withdrawal thresholds for mechanical stimulation was not significantly increased 10 days after chronic constriction injury. CONCLUSION: While transfection with miR-1 mimics effective reduces Cx43 expression in vitro and restores miR-1 after CCI, we did neither observe altered levels of Cx43 protein level in nerves nor a beneficial effect on mechanical allodynia in vivo, most likely caused by insufficient Cx43 suppression. Dove 2020-11-13 /pmc/articles/PMC7671483/ /pubmed/33223847 http://dx.doi.org/10.2147/JPR.S266937 Text en © 2020 Kuebart et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kuebart, Anne
Wollborn, Verena
Huhn, Ragnar
Hermanns, Henning
Werdehausen, Robert
Brandenburger, Timo
Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats
title Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats
title_full Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats
title_fullStr Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats
title_full_unstemmed Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats
title_short Intraneural Application of microRNA-1 Mimetic Nucleotides Does Not Resolve Neuropathic Pain After Chronic Constriction Injury in Rats
title_sort intraneural application of microrna-1 mimetic nucleotides does not resolve neuropathic pain after chronic constriction injury in rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671483/
https://www.ncbi.nlm.nih.gov/pubmed/33223847
http://dx.doi.org/10.2147/JPR.S266937
work_keys_str_mv AT kuebartanne intraneuralapplicationofmicrorna1mimeticnucleotidesdoesnotresolveneuropathicpainafterchronicconstrictioninjuryinrats
AT wollbornverena intraneuralapplicationofmicrorna1mimeticnucleotidesdoesnotresolveneuropathicpainafterchronicconstrictioninjuryinrats
AT huhnragnar intraneuralapplicationofmicrorna1mimeticnucleotidesdoesnotresolveneuropathicpainafterchronicconstrictioninjuryinrats
AT hermannshenning intraneuralapplicationofmicrorna1mimeticnucleotidesdoesnotresolveneuropathicpainafterchronicconstrictioninjuryinrats
AT werdehausenrobert intraneuralapplicationofmicrorna1mimeticnucleotidesdoesnotresolveneuropathicpainafterchronicconstrictioninjuryinrats
AT brandenburgertimo intraneuralapplicationofmicrorna1mimeticnucleotidesdoesnotresolveneuropathicpainafterchronicconstrictioninjuryinrats